Expression of complement C3, C5, C3aR and C5aR1 genes in resting and activated CD4


Journal

Immunobiology
ISSN: 1878-3279
Titre abrégé: Immunobiology
Pays: Netherlands
ID NLM: 8002742

Informations de publication

Date de publication:
03 2019
Historique:
received: 16 11 2018
revised: 21 12 2018
accepted: 21 12 2018
pubmed: 8 1 2019
medline: 10 1 2020
entrez: 8 1 2019
Statut: ppublish

Résumé

Complement activation is traditionally thought to occur in the extracellular space. However, it has been suggested that complement proteins are activated and function at additional locations. T cells contain intracellular stores of C3 and C5 that can be cleaved into C3a and C5a and bind to intracellular receptors, which have been shown to be of vital importance for the differentiation and function of these cells. However, whether the origin of the complement proteins located within T cells is derived from endogenous produced complement or from an uptake dependent mechanism is unknown. The presence of intracellular C3 in T cells from normal donors was investigated by fluorescence microscopy and flow cytometry. Moreover, mRNA expression levels of several genes encoding for complement proteins with primary focus on C3, C3aR, C5 and C5aR1 during resting state and upon activation of CD4

Identifiants

pubmed: 30612786
pii: S0171-2985(18)30206-7
doi: 10.1016/j.imbio.2018.12.004
pii:
doi:

Substances chimiques

Biomarkers 0
C5AR1 protein, human 0
Complement C3 0
Complement C5 0
Receptor, Anaphylatoxin C5a 0
Receptors, Complement 0
complement C3a receptor 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

307-315

Informations de copyright

Copyright © 2018 Elsevier GmbH. All rights reserved.

Auteurs

Cecilie Bo Hansen (CB)

Laboratory of Molecular Medicine, Department of Clinical Immunology Section 7631, Faculty of Health and Medical Sciences, University Hospital of Copenhagen, Denmark.

Anton Willer (A)

Laboratory of Molecular Medicine, Department of Clinical Immunology Section 7631, Faculty of Health and Medical Sciences, University Hospital of Copenhagen, Denmark.

Rafael Bayarri-Olmos (R)

Laboratory of Molecular Medicine, Department of Clinical Immunology Section 7631, Faculty of Health and Medical Sciences, University Hospital of Copenhagen, Denmark.

Claudia Kemper (C)

National Heart, Lung and Blood Institute, National Institute of Health, Bethesda, MD, 20814, USA.

Peter Garred (P)

Laboratory of Molecular Medicine, Department of Clinical Immunology Section 7631, Faculty of Health and Medical Sciences, University Hospital of Copenhagen, Denmark. Electronic address: peter.garred@regionh.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH